Lisdexamfetamine 50 MG capsule 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F67L7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,476
Award facts
- Contract value 100% obligated
- $11,476.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,476.17 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 50 mg capsules (90-count units) on February 4, 2026, with an ultimate completion date of February 5, 2026. This is a firm fixed-price, non-set-aside contract with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at up to $999,999,999.00 and running through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly operating as AmerisourceBergen), a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The parent company, Cencora, Inc., holds multiple significant IDCs with the Defense Logistics Agency and Department of Justice Federal Bureau of Investigation for pharmaceutical and medical commodity delivery. AmerisourceBergen's contract awards demonstrate extensive capability in fulfilling federal medical supply requirements, including prescription medications across multiple therapeutic domains, serving critical customers such as the Defense Health Agency, U.S. Coast Guard, and military treatment facilities. All reviewed contract awards, including this delivery order, are competitively awarded on a full and open basis with no set-aside designations.
Quick answers
Who was awarded contract SPE2DR26F67L7?
SPE2DR26F67L7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F67L7 worth?
The government has obligated $11,476 on SPE2DR26F67L7.
Is contract SPE2DR26F67L7 an order under another contract?
Yes. SPE2DR26F67L7 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F67L7 competed?
The extent of competition for SPE2DR26F67L7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award